Share Email Print
cover

Proceedings Paper

Augmenting convection-enhanced delivery through simultaneous co-delivery of fluids and laser energy with a fiberoptic microneedle device
Author(s): R. Lyle Hood; Tobias Ecker; Rudy Andriani; John Robertson; John Rossmeisl; Christopher G. Rylander
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

This paper describes a new infusion catheter, based on our fiberoptic microneedle device (FMD), designed with the objective of photothermally augmenting the volumetric dispersal of infused therapeutics. We hypothesize that concurrent delivery of laser energy, causing mild localized photothermal heating (4-5 °C), will increase the spatial dispersal of infused chemotherapy over a long infusion period. Agarose brain phantoms, which mimic the brain’s mechanical and fluid conduction properties, were constructed from 0.6 wt% Agarose in aqueous solution. FMDs were fabricated by adhering a multimode fiberoptic to a silica capillary tube, such that their flat-polished tips co-terminated. Continuous wave 1064 nm light was delivered simultaneously with FD&C Blue #2 (5%) dye into phantoms. Preliminary experiments, where co-delivery was tested against fluid delivery alone (through symmetrical infusions into in vivo rodent models), were also conducted. In the Agarose phantoms, volumetric dispersal was demonstrated to increase by more than 3-fold over a four-hour infusion time frame for co-delivery relative to infusion-only controls. Both forward and backward (reflux) infusions were also observed to increase slightly. Increased volumetric dispersal was demonstrated with co-delivery in an in vivo rodent model. Photothermal augmentation of infusion was demonstrated to influence the directionality and increase the volume of dye dispersal in Agarose brain phantoms. With further development, FMDs may enable a greater distribution of chemotherapeutic agents during CED therapy of brain tumors.

Paper Details

Date Published: 20 March 2013
PDF: 11 pages
Proc. SPIE 8576, Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XIII, 85760G (20 March 2013); doi: 10.1117/12.2004854
Show Author Affiliations
R. Lyle Hood, Virginia Polytechnic Institute and State Univ. (United States)
Tobias Ecker, Virginia Polytechnic Institute and State Univ. (United States)
Rudy Andriani, Virginia Polytechnic Institute and State Univ. (United States)
John Robertson, Virginia Polytechnic Institute and State Univ. (United States)
John Rossmeisl, Virginia Polytechnic Institute and State Univ. (United States)
Christopher G. Rylander, Virginia Polytechnic Institute and State Univ. (United States)


Published in SPIE Proceedings Vol. 8576:
Optical Fibers and Sensors for Medical Diagnostics and Treatment Applications XIII
Israel Gannot, Editor(s)

© SPIE. Terms of Use
Back to Top